Welcome to the China·Berpu Medical Technology Co., Ltd.
Phrase I: Introduction of International advanced technology and improvement of China cannula production
1996
BERPU began the production of medical use cannula and BERPU is the earliest company in China who developed the full process production line starting from pipe welding to finished products.
BERPU continues to explore ultra-fine stainless steel tube market in various areas like watches, knitting and cosmetology.
2000
2001
2002
Continuously put into production like sterile syringe, insulin pen needles, insulin syringe, sterile syringe, infusion set, blood collection needles and infusion needles etc., and granted the product registration certificate issued by CFDA.
2003
2004
June Independent research and development auto-assembly line of insulin pen needles and insulin syringe had been put into production， which is earliest in China.
August Part of the products continuously entered into US market.
2005
Safety syringe were put into production.
Phrase II Expand production capacity and ensure more patients to get access to BERPU's high quality needles.
2007
2008
2009
January the Independent research and development needle auto-grinding machine had been officially put into production.
February upgraded the assembly line for hypodermic needle product to lager capacity and better auto-detection.
2010
February Independent research and development second generation of insulin needle assembly line had been formally put into production.
2011
Phrase III Enhance innovation ability to make the needle not only high quality but also safer.
2013
Berpu keeps on product innovation, management innovation, marketing innovation and constant improvement.
Continuously granted with Science and Technology (innovation) enterprises from various levels.
2014
June Began the production of brand-new safety products
December continuously put the brand-new insulin pen needles, insulin syringes, blood collection needles production line into production.
2015
June The new factory in Wenzhou Konggang district start to put into operation with 4.5 times larger (60000㎡) than original one's in building area.
July passed the audit by CFDA.
August passed the site audit by American FDA.
September Renamed as "BERPU MEDICAL TECHNOLOGY CO., LTD." with registration capital of 56 million yuan.
December Achieved the constant high-speed growth for 3 years.
Achieved more than 50 patents for utility models and innovation.
20 years continuous improvement
20 years constant innovation
